BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 9544991)

  • 21. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
    Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
    Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation.
    Ali S; Chen Z; Lebrun JJ; Vogel W; Kharitonenkov A; Kelly PA; Ullrich A
    EMBO J; 1996 Jan; 15(1):135-42. PubMed ID: 8598196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
    Kazansky AV; Kabotyanski EB; Wyszomierski SL; Mancini MA; Rosen JM
    J Biol Chem; 1999 Aug; 274(32):22484-92. PubMed ID: 10428824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA; Waxman DJ
    J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
    Han Y; Watling D; Rogers NC; Stark GR
    Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
    Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
    Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
    Pezet A; Buteau H; Kelly PA; Edery M
    Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD; Dostal D; Baker K
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription.
    Stoecklin E; Wissler M; Moriggl R; Groner B
    Mol Cell Biol; 1997 Nov; 17(11):6708-16. PubMed ID: 9343435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
    Hou Z; Srivastava S; Mistry MJ; Herbst MP; Bailey JP; Horseman ND
    Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.